Department of Neurological Sciences, Rush University Medical Center, Chicago, Ill 60612, USA.
Neurodegener Dis. 2012;10(1-4):216-9. doi: 10.1159/000333122. Epub 2012 Feb 4.
Alterations in the relative abundance of synaptic proteins may contribute to hippocampal synaptic dysfunction in Alzheimer's disease (AD). The extent to which perturbations in synaptic protein expression occur during the earliest stages of cognitive decline remains unclear. We examined protein levels of presynaptic synaptophysin (SYP) and synaptotagmin (SYT), and postsynaptic drebrin (DRB), a marker for dendritic spine plasticity, in the hippocampus of people with an antemortem clinical diagnosis of no cognitive impairment (NCI), mild cognitive impairment (MCI) or mild/moderate AD. Although normalized SYP and SYT levels were preserved, DRB was reduced by approximately 40% in the hippocampus of MCI and AD compared to NCI subjects. This differential alteration of synaptic markers in MCI suggests a selective impairment in hippocampal postsynaptic dendritic plasticity in prodromal AD that likely heralds the onset of memory impairment in symptomatic disease.
突触蛋白相对丰度的改变可能导致阿尔茨海默病(AD)中海马突触功能障碍。在认知能力下降的早期阶段,突触蛋白表达的改变程度尚不清楚。我们检测了无认知障碍(NCI)、轻度认知障碍(MCI)或轻度/中度 AD 患者海马体中突触前突触小泡蛋白(SYP)和突触结合蛋白(SYT)以及突触后树突棘可塑性标志物 drebrin(DRB)的蛋白水平。尽管 SYP 和 SYT 的水平正常化,但与 NCI 受试者相比,MCI 和 AD 患者的 DRB 减少了约 40%。MCI 中突触标志物的这种差异改变表明,在 AD 的前驱期,海马体的突触后树突棘可塑性可能出现选择性损伤,这可能预示着症状性疾病中记忆障碍的发生。